Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Lenalidomide for the Treatment of Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (MT-3724_NHL_003)
Clinical trial NCT03645395 · TERMINATED
Trial details
- NCT number
- NCT03645395
- Sponsor
- Molecular Templates, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-08
- Primary completion
- 2021-03-10
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.